General Information of This Drug (ID: DM4WCF9)

Drug Name
Pelareorep   DM4WCF9

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Phase 3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Non-small-cell lung cancer DIS5Y6R9 2C25.Y Phase 3 [1]
------------------------------------------------------------------------------------
3 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Peritoneal cavity cancer DISBT2JS 2C51.Z Phase 2 [2]
Ovarian cancer DISZJHAP 2C73 Phase 2 [2]
Fallopian tube cancer DISXHWCS 2C74 Phase 2 [2]
------------------------------------------------------------------------------------
1 Phase 1/2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Pancreatic cancer DISJC981 2C10 Phase 1/2 [1]
------------------------------------------------------------------------------------
3 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Malignant glioma DISFXKOV 2A00.0 Phase 1 [2]
Multiple myeloma DISEWP9B 2A83 Phase 1 [1]
Colorectal cancer DISNH7P9 2B91.Z Phase 1 [1]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)